Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

101
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
101
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

108
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
108
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

122
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
122
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

108
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
108
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

43
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
43
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

46
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
46

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Survey Study of Liver Donors' Information Needs on Recipient Outcomes in High-Risk Donation Scenarios.

Progress in transplantation (Aliso Viejo, Calif.)·2025
Same author

Predictors of response to terlipressin therapy in hepatorenal syndrome: Metabolomic and proteomic analysis from the CONFIRM trial.

Hepatology communications·2025
Same author

Recommendations to overcome barriers to transplant fellowship training: A report from the American Society of Transplantation Fellows Task Force.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025
Same author

Metabolomic and proteomic analyses of renal function after liver transplantation.

Frontiers in transplantation·2025
Same author

Home-based LIver FrailTy Intervention (LIFT) in Transplant Candidates: A Feasibility Study.

Transplantation·2025
Same author

Home-based LIver FrailTy Intervention (LIFT) in Transplant Candidates: A Feasibility Study.

Transplantation·2025

Related Experiment Video

Updated: Nov 2, 2025

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

16.3K

Current and Evolving Indications for Simultaneous Liver Kidney Transplantation.

Kathy M Nilles1, Josh Levitsky2

  • 1Division of Gastroenterology and Hepatology, Department of Medicine, MedStar Georgetown Transplant Institute, Georgetown University School of Medicine, Washington, District of Columbia.

Seminars in Liver Disease
|June 15, 2021
PubMed
Summary

This review covers kidney disease in liver transplant candidates and the evolution of simultaneous liver-kidney (SLK) transplantation. It details current SLK indications, policies, and future research needs for this complex procedure.

More Related Videos

Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

16.6K
Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
11:25

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

599

Related Experiment Videos

Last Updated: Nov 2, 2025

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

16.3K
Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

16.6K
Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
11:25

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

599

Area of Science:

  • Nephrology and Hepatology
  • Transplant Medicine
  • Organ Transplantation

Background:

  • Kidney disease is a significant concern for liver transplant candidates.
  • Simultaneous liver-kidney (SLK) transplantation has evolved over time.
  • Understanding the interplay between liver and kidney function is critical.

Purpose of the Study:

  • To review the causes of kidney disease in patients awaiting liver transplants.
  • To trace the historical development of indications for SLK transplantation.
  • To outline current SLK transplant criteria and future research directions.

Main Methods:

  • Literature review of kidney disease etiologies in liver transplant recipients.
  • Historical analysis of SLK transplant indication evolution.
  • Discussion of current Organ Procurement and Transplantation Network (OPTN) policies and MELD exception points.
  • Overview of the kidney transplant safety net policy.

Main Results:

  • Etiologies of kidney disease in liver transplant candidates are multifactorial.
  • SLK transplant indications have expanded based on evolving criteria and outcomes.
  • Current policies guide the selection of appropriate candidates for SLK.

Conclusions:

  • SLK transplantation is a complex procedure with evolving indications.
  • Further research is needed to address unanswered questions in SLK transplantation.
  • Optimizing patient selection and outcomes remains a key focus.